Effect of Soluble CD39 and PD-L1 Levels on Diagnosis and Prognosis of Lung Cancer Patients with Malignant Pleural Effusion

被引:0
|
作者
Chen, M. [1 ]
Li, X. [2 ]
Wan, B. [1 ]
Zhu, S. [2 ]
Chen, C. [1 ]
Zhang, F. [2 ]
Song, Y. [3 ]
Lv, T. [2 ]
机构
[1] Southern Med Univ, Sch Clin Med 1, Jinling Hosp, Dept Resp Med, Guangzhou, Peoples R China
[2] Nanjing Univ, Sch Med, Jinling Hosp, Dept Resp & Crit Care Med, Nanjing, Peoples R China
[3] Nanjing Univ, Sch Med, Jinling Hosp, Nanjing, Peoples R China
关键词
Soluble PD-L1; Soluble CD39; malignant pleural effusion (MPE);
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P36.08
引用
收藏
页码:S437 / S438
页数:2
相关论文
共 50 条
  • [31] Feasibility Of Pd-L1 Expression Testing In Non-Small Cell Lung Cancer From Pleural And Pericardial Effusion Samples
    Kim, J. S.
    Heymann, J. J.
    Pagan, C.
    Crapanzano, J. P.
    Fazlollahi, L.
    Haghighi, M.
    Stoopler, M. B.
    Sonett, J. R.
    Sacher, A. G.
    Shu, C. A.
    Rizvi, N. A.
    Bulman, W. A.
    Saqi, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [32] Plasma Levels of Soluble PD-L1 Correlate With Tumor Regression in Patients With Lung and Gastric Cancer Treated With Immune Checkpoint Inhibitors
    Ando, Kiyohiro
    Hamada, Kazuyuki
    Watanabe, Makoto
    Ohkuma, Ryotaro
    Shida, Midori
    Onoue, Rie
    Kubota, Yutaro
    Matsui, Hiroto
    Ishiguro, Tomoyuki
    Hirasawa, Yuya
    Ariizumi, Hirotsugu
    Tsurutani, Junji
    Yoshimura, Kiyoshi
    Tsunoda, Takuya
    Kobayashi, Shinichi
    Wada, Satoshi
    ANTICANCER RESEARCH, 2019, 39 (09) : 5195 - 5201
  • [33] In a Novel Malignant Pleural Effusion Derived Anaplastic Thyroid Cancer Line PD-L1 Expression is Strongly Increased by HDAC Inhibitor Treatment
    Hegedus, Luca
    Rittler, Dominika
    Garay, Tamas
    Stockhammer, Paul
    Kovacs, Ildiko
    Doeme, Balazs
    Schmid, Kurt W.
    Fuehrer, Dagmar
    Aigner, Clemens
    Hegedus, Balazs
    PNEUMOLOGIE, 2019, 73 (02):
  • [34] Comparative cell-free mutation analysis for diagnosis of malignant pleural effusion in lung cancer patients
    Frille, Armin
    Stiller, Mathias
    Wald, Alexandra
    Seyfarth, Hans-Juergen
    Metze, Michael
    Platz, Martin
    Kruecken, Irene
    Boeschen, Myriam
    Blaeker, Hendrik
    Wirtz, Hubert
    Von Laffert, Maximilian
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [35] Effect of IL-6 elevation in malignant pleural effusion on hyperfibrinogenemia in lung cancer patients
    Yamaguchi, T
    Kimura, H
    Yokota, S
    Yamamoto, Y
    Hashimoto, T
    Nakagawa, M
    Ito, M
    Ogura, T
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2000, 30 (02) : 53 - 58
  • [36] PD1 and CD39 expression on tumor infiltrating lymphocytes in patients with gastric cancer.
    Okayama, Takafumi
    Tsukamoto, Nobuo
    Suzuki, Toshihiro
    Mochizuki, Kiyotaka
    Sano, Junichi
    Nagata, Hiromi
    Terajima, Daiki
    Habu, Takumi
    Yoshida, Mitsumasa
    Sato, Kazuma
    Fujiwara, Naoto
    Yura, Masahiro
    Fujita, Takeo
    Shimomura, Manami
    Oonuki, Kazunobu
    Fukuda, Kyoko
    Uemura, Yasushi
    Nakatsura, Tetsuya
    Kinoshita, Takahiro
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 377 - 377
  • [37] High serum levels of soluble PD-1 and PD-L1 are associated with advanced clinical stages in patients with cervical cancer
    Perez-Picazo, Silvia Elizabeth
    Martinez-Morales, Patricia
    Conde-Rodriguez, Ileana
    Reyes-Leyva, Julio
    Vallejo-Ruiz, Veronica
    BIOMEDICAL REPORTS, 2025, 22 (04)
  • [38] PD-L1 Expression in Patients with Small Cell Lung Cancer
    Wang, Haiyue
    Li, Zhongwu
    Yang, Xin
    Zhou, Lixin
    Lin, Dongmei
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S818 - S818
  • [39] Soluble PD-L1 in Serum and Urine in Urinary Bladder Cancer Patients
    Vikerfors, Anders
    Davidsson, Sabina
    Frey, Janusz
    Jerlstrom, Tomas
    Carlsson, Jessica
    CANCERS, 2021, 13 (22)
  • [40] PD-L1 Status and Survival in Patients With Lung Cancer Reply
    Miller, Peter Grant
    Li, Gerald
    Singal, Gaurav
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2019, 322 (08): : 783 - 784